DSL(603233.SH)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
DSL
603233.SH
DaShenLin Pharmaceutical Group Co., Ltd. manufactures, distributes, and retails pharmaceutical products in China. It offers Chinese and Western patent medicines, ginseng and antler tonic medicinal materials, Chinese herbal medicine slices, health products, medical devices, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China.
85.39 B
603233.SHMarket value -Rank by Market Cap -/-

Financial Score

19/05/2026 Update
B
Drug RetailIndustry
Industry Ranking2/8
Industry medianC
Industry averageB
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE16.90%A
    • Profit Margin4.67%C
    • Gross Margin36.05%C
  • Growth ScoreC
    • Revenue YoY3.07%C
    • Net Profit YoY31.76%B
    • Total Assets YoY0.20%D
    • Net Assets YoY6.39%B
  • Cash ScoreB
    • Cash Flow Margin353.72%A
    • OCF YoY3.07%C
  • Operating ScoreA
    • Turnover1.03A
  • Debt ScoreD
    • Gearing Ratio65.77%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Stigmasterol-Rich Plant Sterols Market to Reach USD 1,281.42 Million by 2036 as Cardiovascular Health Awareness and Functional Food Demand Expand Globally

    MorningStar·
    MorningStar·

    FMI Reveals Bleeding Disorder Testing Market USD 117.1 Billion in 2026 to USD 234.6 Billion by 2036 Driven by Expanding Demand for Performance-Grade Diagnostic Solutions

    MorningStar·
    MorningStar·

    Chinese Rehab Robot Makers Leverage Tech Advantages to Expand Overseas, Experts Say

    Yicai·
    Yicai·

    Policy dividends continue to be released, and the pharmaceutical retail industry welcomes new opportunities for transformation

    Wallstreetcn·
    SH
    512010
    -1.15%
    SH
    603939
    -1.92%
    SZ
    002727
    -2.82%
    Wallstreetcn·
    SH
    512010
    -1.15%
    SH
    603939
    -1.92%
    SZ
    002727
    -2.82%

    Pharmaceutical commercial stocks opened higher, with Yifeng Pharmacy hitting the daily limit, followed by DSL, Jointown, Hezong Medicine Easy-To-Buy Pharmaceutical, SYPM, and LBX. In terms of news, the Ministry of Commerce and 8 other departments issued the "Opinions on Promoting the High-Quality Development of the Pharmaceutical Retail Industry."

    Wallstreetcn·
    SZ
    300937
    -2.57%
    SZ
    301017
    -1.32%
    SH
    603233
    -0.34%
    Wallstreetcn·
    SZ
    300937
    -2.57%
    SZ
    301017
    -1.32%
    SH
    603233
    -0.34%
    © 2026 Longbridge｜Disclaimer